One patient was diagnosed with low density lipoprotein receptor-related protein 5 (LRP5) mutation, one with a type 5 OI with interferon-induced transmembrane protein 5 (IFITM5) mutation confirmed. This evidence concerns the gene IFITM5 and osteogenesis imperfecta.